Samsung may separate its foundry business from its semiconductor division. This move addresses conflict of interest concerns.

Samsung Electronics is again facing speculations that it may spin off its foundry business from the broader semiconductor ...

Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar ...

Samsung Biologics, the biotech arm of Samsung, said Monday that its contract manufacturing organization (CMO) deals have ...

16 for final approval. Samsung Biologics explained that the split will allow the company to concentrate resources on its CDMO business, which operates under a different revenue model compared to ...

Samsung Biologics announced on the 22nd that it will establish 'Samsung Bioepis Holdings' through a simple spin-off method. The plan is to completely separate the contract development and ...

SEOUL :South Korean drug maker Samsung BioLogics said on Thursday it plans to separate the company into contract manufacturing and development companies, to help allay customer concerns about ...

Samsung Biologics announced on May 22 that it will spin off its biosimilar unit, Samsung Bioepis, to create a new holding company tentatively named Samsung Epis Holdings. The new company will oversee ...

Samsung Biologics announced on the 22nd that it would establish a new holding company, "Samsung Bioepis Holdings," through a simple spin-off partitioning method, completely separating its contract ...